Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
- PMID: 32876935
- PMCID: PMC7522109
- DOI: 10.1007/s40265-020-01392-y
Correction to: Risankizumab: A Review in Moderate to Severe Plaque Psoriasis
Abstract
The original article can be found online.
Erratum for
-
Risankizumab: A Review in Moderate to Severe Plaque Psoriasis.Drugs. 2020 Aug;80(12):1235-1245. doi: 10.1007/s40265-020-01357-1. Drugs. 2020. PMID: 32632826 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
